SCHEMBL8907751

SCHEMBL8907751

O=c1cnc2c([nH]1)-c1ccccc1C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 1/20 0.45
DAPK3 O43293 1/20 0.45
PIM1 P11309 1/20 0.45
PDGFRA P16234 1/20 0.45
LTK P29376 1/20 0.45
MAP2K2 P36507 1/20 0.45
FLT3 P36888 1/20 0.45
MAPK8 P45983 1/20 0.45
MAPK9 P45984 1/20 0.45
CSNK1A1 P48729 1/20 0.45
TDO2 P48775 1/20 0.45
CDK8 P49336 1/20 0.45
CDK5 Q00535 1/20 0.45
MAP2K1 Q02750 1/20 0.45
MST1R Q04912 1/20 0.45
PTK2 Q05397 1/20 0.45
MAP4K2 Q12851 1/20 0.45
ROCK1 Q13464 1/20 0.45
DYRK1A Q13627 1/20 0.45
LRRK2 Q5S007 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1164890 0.72 MAOA (0.52) PLK4DAPK3PIM1PDGFRALTK
SCHEMBL30608987 0.70 ALDH1A1 (0.53) PLK4DAPK3PIM1PDGFRALTK
SCHEMBL9815972 0.69 PTPRC (0.42) TDO2TDP2CES1ALDH1A1
SCHEMBL12294422 0.69 TYMS (0.49) PLK4DAPK3PIM1PDGFRALTK
SCHEMBL8908559 0.67 ALDH1A1 (0.53) TDO2ALDH1A1
SCHEMBL6025692 0.67 MAOA (0.61) MAOATDP2BCHECES1ALDH1A1
SCHEMBL6237073 0.67 POLB (0.58) TDO2ALDH1A1
SCHEMBL12294449 0.66 KDM4E (0.45) PLK4DAPK3PIM1PDGFRALTK
SCHEMBL30011414 0.65 METAP2 (0.46) PLK4DAPK3PIM1PDGFRALTK
SCHEMBL51294 0.65 METAP2 (0.46) PLK4DAPK3PIM1PDGFRALTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682657-B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1997-11-19 EP disclosed
EP-0682657-B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1997-11-19 EP disclosed
US-5646146-A CENTRAL NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1997-07-08 US disclosed
US-5646146-A CENTRAL NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1997-07-08 US disclosed
EP-0682657-A1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-11-22 EP disclosed
EP-0682657-A1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-11-22 EP disclosed
US-5468748-A Nervous system and psychological disorders; antagonize glycine binding site on N-methylaspartic acid receptor complex NOVO NORDISK A/S (DK) 1995-11-21 US disclosed
US-5468748-A Nervous system and psychological disorders; antagonize glycine binding site on N-methylaspartic acid receptor complex NOVO NORDISK A/S (DK) 1995-11-21 US disclosed
WO-1994018175-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-08-18 WO disclosed
WO-1994018175-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-08-18 WO disclosed